Vimarsana
Biggest News Aggregation in the World

Controlled Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Controlled Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Controlled Phase Today - Breaking & Trending Today

Clinical Phase III Trial Results Demonstrating Sovateltide's Efficacy to Treat Acute Cerebral Ischemic Stroke Presented at The International Stroke Conference 2023 - Vimarsana News

Clinical Phase III Trial Results Demonstrating Sovateltide's Efficacy to Treat Acute Cerebral Ischemic Stroke Presented at The International Stroke Conference 2023

/PRNewswire/ -- Pharmazz, Inc. ("Pharmazz"), a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in...

CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition - Vimarsana News

CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at...

CTI BioPharma Reports Third Quarter 2022 Financial Results - Vimarsana News

CTI BioPharma Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the third quarter ended September 30, 2022....

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated - Vimarsana News

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Researchers report the phase II efficacy and safety of molnupiravir in both unvaccinated and vaccinated individuals.

Amgen Announces New Data Being Presented At ASH 2021 - Vimarsana News

Amgen Announces New Data Being Presented At ASH 2021

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from its hematology pipeline and marketed portfolio to be presented at the 63rd American Society...